David A Barbie Selected Research

David A Barbie Research Topics

Disease

64	Neoplasms (Cancer) 05/2024 - 06/2004
11	Lung Neoplasms (Lung Cancer) 12/2023 - 04/2014
10	Bites and Stings (Sting) 01/2024 - 01/2019
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 01/2017
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2017
5	Adenocarcinoma of Lung 01/2021 - 04/2014
4	Carcinogenesis 02/2017 - 07/2009
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 10/2019
3	Breast Neoplasms (Breast Cancer) 02/2017 - 07/2009
2	Adenocarcinoma 02/2024 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2021
2	Ascites 08/2023 - 11/2004
2	Microsatellite Instability 01/2018 - 01/2017
1	Disease Progression 02/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2024
1	Circulating Neoplastic Cells 08/2023
1	Brain Neoplasms (Brain Tumor) 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2022
1	Neuroblastoma 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 07/2022
1	Mesothelioma 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021

Drug/Important Bio-Agent (IBA)

16	Immune Checkpoint InhibitorsIBA 01/2024 - 08/2015
12	CytokinesIBA 01/2024 - 04/2014
8	InterferonsIBA 01/2024 - 01/2019
7	Phosphotransferases (Kinase)IBA 01/2023 - 05/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 11/2004
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2017
5	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2022
5	Interleukin-6 (Interleukin 6)IBA 08/2023 - 04/2014
5	ChemokinesIBA 01/2023 - 01/2016
5	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2018
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2018 - 04/2014
4	Programmed Cell Death 1 ReceptorIBA 05/2024 - 01/2018
4	AntibodiesIBA 11/2022 - 03/2016
4	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2018
4	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 11/2018 - 04/2014
3	AntigensIBA 01/2024 - 01/2017
2	Interferon Type IIBA 12/2023 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2018
2	MethyltransferasesIBA 01/2023 - 07/2014
2	LigandsIBA 10/2022 - 03/2016
2	ErbB Receptors (EGF Receptor)IBA 09/2021 - 01/2020
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2021 - 12/2003
2	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2021 - 01/2020
2	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2020 - 10/2018
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2018 - 01/2018
2	Retinoblastoma ProteinIBA 02/2017 - 06/2004
2	SuspensionsIBA 12/2016 - 01/2016
1	B7-H1 AntigenIBA 05/2024
1	Exonucleases (3' 5' Exonuclease)IBA 05/2024
1	Histone MethyltransferasesIBA 02/2024
1	Enhancer of Zeste Homolog 2 ProteinIBA 02/2024
1	Nucleic AcidsIBA 01/2024
1	exodeoxyribonuclease IIBA 01/2024
1	Carbonic Anhydrase IXIBA 01/2024
1	Therapeutic UsesIBA 01/2024
1	Doxycycline (Periostat)FDA LinkGeneric 01/2024
1	EpitopesIBA 01/2024
1	Glycoproteins (Glycoprotein)IBA 12/2023
1	Death Domain ReceptorsIBA 12/2023
1	Adenosine (Adenocard)FDA LinkGeneric 12/2023
1	Angiogenesis InhibitorsIBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023
1	Chemokine CCL5IBA 08/2023
1	Epithelial Cell Adhesion MoleculeIBA 08/2023
1	Cell Adhesion MoleculesIBA 01/2023
1	RNA Helicases (RNA Helicase)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Eukaryotic Initiation Factor-4F (EIF4F)IBA 01/2023
1	ADU-S100IBA 12/2022
1	Cancer VaccinesIBA 12/2022
1	CTLA-4 AntigenIBA 11/2022
1	Pemetrexed (MTA)FDA Link 11/2022
1	Adenosine Monophosphate (AMP)IBA 10/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 10/2022
1	MesothelinIBA 01/2022
1	Histone DemethylasesIBA 01/2022
1	Messenger RNA (mRNA)IBA 09/2021
1	OsteopontinIBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	SOXB1 Transcription FactorsIBA 01/2021
1	E-SelectinIBA 01/2020
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2020
1	neratinibIBA 01/2020
1	Ligases (Synthetase)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Drug CombinationsIBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	UbiquitinIBA 01/2020

Therapy/Procedure

32	Therapeutics 02/2024 - 12/2003
20	Immunotherapy 08/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 11/2018 - 01/2018
2	Precision Medicine 12/2019 - 01/2017
1	Castration 02/2024
1	Lab-On-A-Chip Devices 01/2020